Exposed Hypersensitive Dentin Treated With Fluoride Iontophoresis With Remineralizing Agents

NCT ID: NCT06837779

Last Updated: 2025-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if the application of fluoride works to treat patients suffering from dentin hypersensitivity. It will also learn about the safety of using fluoride iontophoresis with Acidulated phosphate fluoride gel.

The main questions it aims to answer are:

Does the remineralizing agent have the ability to decrease dentin sensitivity?

Researchers will compare Fluoride Iontophoresis with Acidulated Phosphate Fluoride gel , Casein phosphopeptides-Amorphus calcium phosphate (CPP-ACP), nano-hydroxyapptite (NHAP) and -active glass in decreasing dentin hypersensitivity

.

Participants will:

* Application of remineralizing agent every 3 months
* Visit the dental clinic once every 3 months for checkups and tests

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Assess the efficacy of fluoride iontophoresis in remineralization in comparison with other ingredients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fluoride Iontophoresis with Acidulated Phosphate Fluoride gel

assessmen of iontophoresis effect on flouride ions flush to remineralization of demineralized enamel .The treatment will be assessed and recorded using VAS score immediately after the intervention, 3 months, 6 months and one year later.

Group Type EXPERIMENTAL

Fluoride Iontophoresis with Acidulated Phosphate Fluoride

Intervention Type DRUG

Application of fluoride gel and activated with Iontophoresis electrical pole

remineralizing agents

All remineralizing agents (Casein phosphopeptides -Amorphus Calcium Phosphate, Nano-hydroxyapatite, and Bioactive glass).

Group Type ACTIVE_COMPARATOR

Remineralization with sodium fluoride varnish

Intervention Type DRUG

CASIN PHOSPHOPEPTIDE AMORPHOUS CALCIUM PHOSPHATE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluoride Iontophoresis with Acidulated Phosphate Fluoride

Application of fluoride gel and activated with Iontophoresis electrical pole

Intervention Type DRUG

Remineralization with sodium fluoride varnish

CASIN PHOSPHOPEPTIDE AMORPHOUS CALCIUM PHOSPHATE

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients within 35-60 years of age.
* Each patient has 4 or more exposed roots of posterior teeth having sensitivity.
* Good oral hygiene.
* Patients who will agree to the consent and will commit to the follow-up period.
* Patients will follow instructions during study time.
* Teeth that were vital.

Exclusion Criteria

* Patients with any systemic disease that may affect normal healing.
* Patient with bad oral hygiene, high caries index and high plaque index
* Patients participating in more than 1 dental study.
* Active carious lesions.
* Intrinsic and extrinsic stains.
* Any previous filling of selected teeth.
* Cracked and malformed teeth.
Minimum Eligible Age

35 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Wakwak

ASSOCITE PROFESSOR OF OPERATIVE DENTISTRY

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed Wakwak, A

Role: PRINCIPAL_INVESTIGATOR

Alazhar Univeristy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dental Medicine ,Alazhar Univerisity

Cairo, Cairo Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FDAZUC-REC1009/2074

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

New Vital Pulpotomy Medications in Primary Molars
NCT05937100 ACTIVE_NOT_RECRUITING NA